Crypto
XRP ETF Debut Breaks Records but Price Slips Below $3
The first US-listed XRP ETF debuted with $37.7 million in trading, the strongest ETF launch of 2025. Yet XRP fell 3.5%, from $3.01 to $2.91, as heavy profit-taking triggered $8 million in liquidations. Resistance at $3.00 remains key, with Fed rate decisions and sustained buying power likely shaping XRP’s short-term outlook.

The launch of the first US-listed XRP ETF could have been a milestone for the cryptocurrency. Instead, the price came under pressure: Within 24 hours, XRP lost around 3.5 percent of its value, falling from $3.01 to a daily low of $2.91. A particularly notable crash at midnight was a trading volume of over 261 million XRP, four times its usual volume.
XRP ETF launch sets records – and profit-taking
On September 21st, the first XRP ETF launched in the US and, with $37.7 million in first-day trading, recorded the strongest ETF debut of 2025 so far. Nevertheless, institutional investors apparently used the opportunity primarily to take profits. Instead of further upside potential, a sell-off ensued, significantly pushing the price down in the short term.
Technical brands in focus
Technically, the zone between $2.98 and $3.00 currently represents a massive hurdle. Several attempts to recapture this level have failed due to high selling pressure.
On the downside, however, a support zone is forming between $2.91 and $2.92. Traders are watching to see whether this area can be defended sustainably or whether further declines are imminent.
Market environment: Fed decision on XRP ETF approaches
In addition to the ETF euphoria, US monetary policy is also playing a crucial role. Many market participants expect the US Federal Reserve to cut interest rates in September.
Such steps are generally considered a positive stimulus for risky assets like cryptocurrencies. However, whether this effect will be sufficient to push XRP back above the $3 mark remains to be seen.
Outlook: Between consolidation and new upswing
Despite the ETF’s brilliant launch, the market remains skeptical for now. The high sales volume and numerous liquidations – almost $8 million, especially in long positions – point to ongoing uncertainty.
The decisive factor now will be whether XRP can mobilize enough buying power in the coming days to overcome the resistance level at $3.00. If this succeeds, the new ETF instrument could attract fresh liquidity and investors in the long term.
Conclusion
Although the XRP ETF had a record start, profit-taking and technical resistance dominated in the short term. The coming weeks will show whether the cryptocurrency can stabilize above $3 or whether a longer consolidation phase is imminent.
__
(Featured image by Dmytro Demidko via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BLCOK-BUILDERS.DE. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

-
Biotech7 days ago
Delphi-2M: AI Model Predicts Multi-Disease Risks and Supports Precision Healthcare
-
Crowdfunding2 weeks ago
Real Estate Crowdfunding Surges in 2024, Nears €55B Globally
-
Crowdfunding3 days ago
UpsideTown Marks Sixth Successful Exit with Strong Investor Returns
-
Crowdfunding1 week ago
PreAste Launches Crowdfunding to Simplify NPL Investments in Italy